Optimization of adenoviral gene transfer in human pluripotent stem cells
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 541, 78-83
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 14 references indexed in Scilit:
- Pluripotent Stem Cell-Based Cell Therapy—Promise and ChallengesCell Stem Cell, 2020
- Defining Human PluripotencyCell Stem Cell, 2019
- A Novel Construction of Lentiviral Vectors for Eliminating Tumorigenic Cells from Pluripotent Stem CellsStem Cells, 2017
- Conditionally replicating adenovirus prevents pluripotent stem cell–derived teratoma by specifically eliminating undifferentiated cellsMolecular Therapy - Methods & Clinical Development, 2015
- Adenovirus: The First Effective In Vivo Gene Delivery VectorHuman Gene Therapy, 2014
- Human Embryonic Stem Cells and Gene TherapyMolecular Therapy, 2007
- Identification and Isolation of Embryonic Stem Cell-Derived Target Cells by Adenoviral Conditional TargetingMolecular Therapy, 2006
- An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in miceHepatology, 2003
- Adenovirus gene transfer vector toxicity to mouse embryos: implications for human IVFHuman Reproduction, 2002
- A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knobGene Therapy, 2001